Research Article

Characteristic of thyroid carcinoma based on age, sex and histology type at Sanglah General Hospital, Bali, Indonesia, 2016

Kishan Arrumugam , Ni Putu Ekawati, I Made Gotra

Kishan Arrumugam
Undergraduate of Faculty of Medicine, Udayana University, Bali, Indonesia.. Email: kishan_arrumugam@yahoo.com

Ni Putu Ekawati
Department of Anatomical Pathology, Faculty of Medicine, Udayana University, Sanglah General Hospital, Bali, Indonesia.

I Made Gotra
Department of Anatomical Pathology, Faculty of Medicine, Udayana University, Sanglah General Hospital, Bali, Indonesia.
Online First: December 01, 2018 | Cite this Article
Arrumugam, K., Ekawati, N., Gotra, I. 2018. Characteristic of thyroid carcinoma based on age, sex and histology type at Sanglah General Hospital, Bali, Indonesia, 2016. Intisari Sains Medis 9(3). DOI:10.15562/ism.v9i3.285


Background: Thyroid cancer is one of the most common malignancies in the endocrine system whereas the annual mortality rate is increasing each year in Indonesia. This study aims to determine characteristic of thyroid carcinoma based on age, sex, and histology type at Sanglah General Hospital, Bali, Indonesia, 2016.

Methods: A cross-sectional study was carried out among 84 patients with thyroid carcinoma at Sanglah General Hospital during January-December 2016. Data were analyzed using secondary data from medical record based on age, sex, and histology type by SPSS ver. 16.

Results: The highest prevalence of thyroid carcinoma based on age was found in the 50-54 years group (17.86%). Females were predominant that attributed to 73.8% compared with males (26.2%). In addition, papillary thyroid carcinoma has the highest prevalence in both sexes that is 75% among other types.

Conclusion: A 50-54 years-age group, females, and papillary thyroid carcinoma types were predominant at Sanglah General Hospital in 2016.

References

Burch H. Follow –up strategy in papillary thyroid cancer. In: Wartofsky L, Van Nostrand D, editors. Thyroid cancer: a comprehensive guide to clinical management. 2nd ed. Totowa: Humana Press; 2006; 289–92.

Quang TN, Lee EJ, Huang MG, Park YI, Khullar A, Plodkowski RA. Diagnosis and Treatment of Patients with Thyroid Cancer. Am Health Drug Benefits. 2015; 8(1): 30–40.

Schonfeld S, Ron E, Kitahara C, Brenner A, Park Y, Sigurdson A, Schatzkin A, González A. Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH-AARP Diet and Health Study. Cancer Epidemiology. 2011; 35(6):e85-e90.

Brown RL, de Souza JA, Cohen, E. Thyroid Cancer: Burden of Illness and Management of Disease. J Cancer. 2011; 2:193-199.

Katoh H, Yamashita K, Enomoto T, Watanabe M. Classification and General Considerations of Thyroid Cancer. Ann Clin Pathol. 2015; 3(1):1045

Yassin F. Diagnostic criteria of well differentiated thyroid tumor of uncertain malignant potential; a histomorphological and immunohistochemical appraisal. Journal of the Egyptian National Cancer Institute. 2015; 27(2):59-67.

Pellegriti G, Frasca F, Regalbuto, C., Squatrito, S. and Vigneri, R. Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors. Journal of Cancer Epidemiology. 2013; 1-10.

Schneider D, Chen H. New developments in the diagnosis and treatment of thyroid cancer. CA: A Cancer Journal for Clinicians. 2013; 63(6):373-394.

Thyroid Carcinoma Task Force AACE/AAES Medical/Surgical Guidelines for Clinical Practice: Management of Thyroid Carcinoma. Endocrine Practice. 2001; 7(3):202-220.

Pramod T, Shivaswamy BS, Ananth G, Rajashekara Babu G, Latha K, Jagadeesh K. Clinical Study of Carcinoma Thyroid and its Management. Int J Sci Stud 2016;3(10):36-42


No Supplementary Material available for this article.
Article Views      : 126
PDF Downloads : 23